What is Emulait?
Founded in 2019, Emulait is pioneering the first baby feeding system engineered to replicate the experience of breastfeeding. Through four years of dedicated research, the company has developed seven patented technologies, utilizing 3D scanning and FDA-approved medical-grade materials. Emulait's core innovation lies in its ability to precisely mimic the mother's breast in terms of shape, color, elasticity, texture, and feel, thereby offering an unparalleled bottle-feeding experience. The company aims to bridge the gap between breast and bottle feeding permanently.
How much funding has Emulait raised?
Emulait has raised a total of $14M across 2 funding rounds:
Series A
$11M
Private Equity
$3M
Series A (2023): $11M, investors not publicly disclosed
Private Equity (2025): $3M, investors not publicly disclosed
What's next for Emulait?
The recent major strategic investment signals a pivotal growth phase for Emulait, likely indicating a Series A or later stage of development, focused on scaling production, expanding market reach, and further research and development. This influx of capital is expected to accelerate Emulait's mission to provide a superior feeding solution for infants, potentially positioning the company as a leader in the specialized baby care market. Future endeavors may include broader distribution channels and enhanced product iterations.
See full Emulait company page
